1
|
Bergquist J, Tarkowski A, Ekman R and
Ewing A: Discovery of endogenous catecholamines in lymphocytes and
evidence for catecholamine regulation of lymphocyte function via an
autocrine loop. Proc Natl Acad Sci USA. 91:12912–12916. 1994.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Josefsson E, Bergquist J, Ekman R and
Tarkowski A: Catecholamines are synthesized by mouse lymphocytes
and regulate function of these cells by induction of apoptosis.
Immunology. 88:140–146. 1996. View Article : Google Scholar : PubMed/NCBI
|
3
|
Musso NR, Brenci S, Setti M, Indiveri F
and Lotti G: Catecholamine content and in vitro catecholamine
synthesis in peripheral human lymphocytes. J Clin Endocrinol Metab.
81:3553–3557. 1996.PubMed/NCBI
|
4
|
Marino F, Cosentino M, Bombelli R, Ferrari
M, Lecchini S and Frigo G: Endogenous catecholamine synthesis,
metabolism storage, and uptake in human peripheral blood
mononuclear cells. Exp Hematol. 27:489–495. 1999. View Article : Google Scholar : PubMed/NCBI
|
5
|
Cosentino M, Marino F, Bombelli R, Ferrari
M, Lecchini S and Frigo G: Endogenous catecholamine synthesis,
metabolism, storage and uptake in human neutrophils. Life Sci.
64:975–981. 1999. View Article : Google Scholar : PubMed/NCBI
|
6
|
Cosentino M, Bombelli R, Ferrari M, Marino
F, Rasini E, Maestroni GJ, Conti A, Boveri M, Lecchini S and Frigo
G: HPLC-ED measurement of endogenous catecholamines in human immune
cells and hematopoietic cell lines. Life Sci. 68:283–295. 2000.
View Article : Google Scholar
|
7
|
Cosentino M, Fietta AM, Ferrari M, Rasini
E, Bombelli R, Carcano E, Saporiti F, Meloni F, Marino F and
Lecchini S: Human CD4+CD25+ regulatory T
cells selectively express tyrosine hydroxylase and contain
endogenous catecholamines subserving an autocrine/paracrine
inhibitory functional loop. Blood. 109:632–642. 2007. View Article : Google Scholar
|
8
|
Cosentino M, Marino F and Lecchini S:
Resistance of naturally occurring regulatory T cells toward
oxidative stress: Possible link with intracellular catecholamine
content and implications for cancer therapy. Blood. 114:487–489.
2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Qiu YH, Peng YP, Jiang JM and Wang JJ:
Expression of tyrosine hydroxylase in lymphocytes and effect of
endogenous catecholamines on lymphocyte function.
Neuroimmunomodulation. 11:75–83. 2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Qiu YH, Cheng C, Dai L and Peng YP: Effect
of endogenous catecholamines in lymphocytes on lymphocyte function.
J Neuroimmunol. 167:45–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Peng YP, Qiu YH, Jiang JL and Wang JJ:
Effect of catecholamines on IL-2 production and NK cytotoxicity of
rats in vitro. Acta Pharmacol Sin. 25:1354–1360. 2004.PubMed/NCBI
|
12
|
Jiang JL, Peng YP, Qiu YH and Wang JJ:
Effect of endogenous catecholamines on apoptosis of Con A-activated
lymphocytes of rats. J Neuroimmunol. 192:79–88. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
D'Ambrosio D, Iellem A, Colantonio L,
Clissi B, Pardi R and Sinigaglia F: Localization of Th-cell subsets
in inflammation: Differential thresholds for extravasation of Th1
and Th2 cells. Immunol Today. 21:183–186. 2000. View Article : Google Scholar : PubMed/NCBI
|
14
|
Willheim M, Ebner C, Baier K, Kern W,
Schrattbauer K, Thien R, Kraft D, Breiteneder H, Reinisch W and
Scheiner O: Cell surface characterization of T lymphocytes and
allergen-specific T cell clones: Correlation of CD26 expression
with T(H1) subsets. J Allergy Clin Immunol. 100:348–355. 1997.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Del Prete G, De Carli M, Almerigogna F,
Daniel CK, D'Elios MM, Zancuoghi G, Vinante F, Pizzolo G and
Romagnani S: Preferential expression of CD30 by human
CD4+ T cells producing Th2-type cytokines. FASEB J.
9:81–86. 1995.PubMed/NCBI
|
16
|
Kidd P: Th1/Th2 balance: The hypothesis,
its limitations, and implications for health and disease. Altern
Med Rev. 8:223–246. 2003.PubMed/NCBI
|
17
|
Simon AK, Seipelt E and Sieper J:
Divergent T-cell cytokine patterns in inflammatory arthritis. Proc
Natl Acad Sci USA. 91:8562–8566. 1994. View Article : Google Scholar : PubMed/NCBI
|
18
|
Dolff S, Bijl M, Huitema MG, Limburg PC,
Kallenberg CG and Abdulahad WH: Disturbed Th1, Th2, Th17 and T(reg)
balance in patients with systemic lupus erythematosus. Clin
Immunol. 141:197–204. 2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Borgogni E, Sarchielli E, Sottili M,
Santarlasci V, Cosmi L, Gelmini S, Lombardi A, Cantini G, Perigli
G, Luconi M, et al: Elocalcitol inhibits inflammatory responses in
human thyroid cells and T cells. Endocrinology. 149:3626–3634.
2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Bleotu C, Chifiriuc MC, Grigore R, Grancea
C, Popescu CR, Anton G and Cernescu C: Investigation of Th1/Th2
cytokine profiles in patients with laryngo-pharyngeal, HPV-positive
cancers. Eur Arch Otorhinolaryngol. 270:711–718. 2013. View Article : Google Scholar
|
21
|
Salicrú AN, Sams CF and Marshall GD:
Cooperative effects of corticosteroids and catecholamines upon
immune deviation of the type-1/type-2 cytokine balance in favor of
type-2 expression in human peripheral blood mononuclear cells.
Brain Behav Immun. 21:913–920. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Huang HW, Tang JL, Han XH, Peng YP and Qiu
YH: Lymphocyte-derived catecholamines induce a shift of Th1/Th2
balance toward Th2 polarization. Neuroimmunomodulation. 20:1–8.
2013. View Article : Google Scholar
|
23
|
Huang HW, Fang XX, Wang XQ, Peng YP and
Qiu YH: Regulation of differentiation and function of helper T
cells by lymphocyte-derived catecholamines via α1- and
β2-adrenoceptors. Neuroimmunomodulation. 22:138–151.
2015. View Article : Google Scholar
|
24
|
Switzer KC, Fan YY, Wang N, McMurray DN
and Chapkin RS: Dietary n-3 polyunsaturated fatty acids promote
activation-induced cell death in Th1-polarized murine
CD4+ T-cells. J Lipid Res. 45:1482–1492. 2004.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Cosentino M, Marino F, Bombelli R, Ferrari
M, Rasini E, Lecchini S and Frigo G: Stimulation with
phytohaemagglutinin induces the synthesis of catecholamines in
human peripheral blood mononuclear cells: Role of protein kinase C
and contribution of intracellular calcium. J Neuroimmunol.
125:125–133. 2002. View Article : Google Scholar : PubMed/NCBI
|
26
|
Cosentino M, Zaffaroni M, Marino F,
Bombelli R, Ferrari M, Rasini E, Lecchini S, Ghezzi A and Frigo G:
Catecholamine production and tyrosine hydroxylase expression in
peripheral blood mononuclear cells from multiple sclerosis
patients: Effect of cell stimulation and possible relevance for
activation-induced apoptosis. J Neuroimmunol. 133:233–240. 2002.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Elenkov IJ, Papanicolaou DA, Wilder RL and
Chrousos GP: Modulatory effects of glucocorticoids and
catecholamines on human interleukin-12 and interleukin-10
production: Clinical implications. Proc Assoc Am Physicians.
108:374–381. 1996.PubMed/NCBI
|
28
|
Takayanagi Y, Osawa S, Ikuma M, Takagaki
K, Zhang J, Hamaya Y, Yamada T, Sugimoto M, Furuta T, Miyajima H
and Sugimoto K: Norepinephrine suppresses IFN-γ and TNF-α
production by murine intestinal intraepithelial lymphocytes via the
β1 adrenoceptor. J Neuroimmunol. 245:66–74. 2012.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Loza MJ, Peters SP, Foster S, Khan IU and
Penn RB: beta-Agonist enhances type 2 T-cell survival and
accumulation. J Allergy Clin Immunol. 119:235–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Musso NR, Brenci S, Indiveri F and Lotti
G: Acetylcholine-induced, calcium-dependent norepinephrine outflow
from peripheral human lymphocytes. J Neuroimmunol. 87:82–87. 1998.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Engler KL, Rudd ML, Ryan JJ, Stewart JK
and Fischer-Stenger K: Autocrine actions of macrophage-derived
catecholamines on interleukin-1 β. J Neuroimmunol. 160:87–91. 2005.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Lajevic MD, Suleiman S, Cohen RL and
Chambers DA: Activation of p38 mitogen-activated protein kinase by
norepinephrine in T-lineage cells. Immunology. 132:197–208. 2011.
View Article : Google Scholar :
|
33
|
Oostendorp J, Obels PP, Terpstra AR,
Nelemans SA and Zaagsma J: Modulation of beta2- and
beta3-adrenoceptor-mediated relaxation of rat oesophagus smooth
muscle by protein kinase C. Eur J Pharmacol. 495:75–81. 2004.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Boterman M, Smits SR, Meurs H and Zaagsma
J: Protein kinase C potentiates homologous desensitization of the
beta2-adrenoceptor in bovine tracheal smooth muscle. Eur J
Pharmacol. 529:151–156. 2006. View Article : Google Scholar
|
35
|
Tran TM, Friedman J, Qunaibi E, Baameur F,
Moore RH and Clark RB: Characterization of agonist stimulation of
cAMP-dependent protein kinase and G protein-coupled receptor kinase
phosphorylation of the beta2-adrenergic receptor using
phosphoserine-specific antibodies. Mol Pharmacol. 65:196–206. 2004.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Violin JD, DiPilato LM, Yildirim N, Elston
TC, Zhang J and Lefkowitz RJ: beta2-adrenergic receptor signaling
and desensitization elucidated by quantitative modeling of
real-time cAMP dynamics. J Biol Chem. 283:2949–2961. 2008.
View Article : Google Scholar
|
37
|
Hennenberg M, Strittmatter F, Walther S,
Hedlund P, Andersson KE, Stief CG, Schlenker B and Gratzke C:
α1-adrenoceptor activation induces phosphorylation of
β2-adrenoceptors in human prostate tissue. BJU Int.
108:922–928. 2011.PubMed/NCBI
|
38
|
Daaka Y, Luttrell LM and Lefkowitz RJ:
Switching of the coupling of the beta2-adrenergic receptor to
different G proteins by protein kinase A. Nature. 390:88–91. 1997.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Zamah AM, Delahunty M, Luttrell LM and
Lefkowitz RJ: Protein kinase A-mediated phosphorylation of the beta
2-adrenergic receptor regulates its coupling to Gs and Gi.
Demonstration in a reconstituted system. J Biol Chem.
277:31249–31256. 2002. View Article : Google Scholar : PubMed/NCBI
|
40
|
Horwitz DA, Gray JD, Behrendsen SC, Kubin
M, Rengaraju M, Ohtsuka K and Trinchieri G: Decreased production of
interleukin-12 and other Th1-type cytokines in patients with
recent-onset systemic lupus erythematosus. Arthritis Rheum.
41:838–844. 1998. View Article : Google Scholar : PubMed/NCBI
|
41
|
Nakashima H, Akahoshi M and Masutani K:
Th1/Th2 balance of SLE patients with lupus nephritis. Rinsho Byori.
54:706–713. 2006.PubMed/NCBI
|
42
|
Ruschpler P and Stiehl P: Shift in Th1
(IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance
within two new histological main-types of rheumatoid-arthritis
(RA). Cell Mol Biol (Noisy-le-grand). 48:285–293. 2002.
|
43
|
Fuse K, Kodama M, Ito M, Okura Y, Kato K,
Hanawa H, Aoki S and Aizawa Y: Polarity of helper T cell subsets
represents disease nature and clinical course of experimental
autoimmune myocarditis in rats. Clin Exp Immunol. 134:403–408.
2003. View Article : Google Scholar : PubMed/NCBI
|
44
|
Garren H, Ruiz PJ, Watkins TA, Fontoura P,
Nguyen LT, Estline ER, Hirschberg DL and Steinman L: Combination of
gene delivery and DNA vaccination to protect from and reverse Th1
autoimmune disease via deviation to the Th2 pathway. Immunity.
15:15–22. 2001. View Article : Google Scholar : PubMed/NCBI
|
45
|
Miyamoto K, Miyake S and Yamamura T: A
synthetic glycolipid prevents autoimmune encephalomyelitis by
inducing TH2 bias of natural killer T cells. Nature. 413:531–534.
2001. View Article : Google Scholar : PubMed/NCBI
|